BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28125080)

  • 41. American College of Medical Genetics position statement on gene patents and accessibility of gene testing.
    Genet Med; 1999; 1(5):237. PubMed ID: 11256680
    [No Abstract]   [Full Text] [Related]  

  • 42. Laboratory analysis of organic acids, 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Gallagher RC; Pollard L; Scott AI; Huguenin S; Goodman S; Sun Q;
    Genet Med; 2018 Jul; 20(7):683-691. PubMed ID: 29543224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical, technical, and environmental biases influencing equitable access to clinical genetics/genomics testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
    Matalon DR; Zepeda-Mendoza CJ; Aarabi M; Brown K; Fullerton SM; Kaur S; Quintero-Rivera F; Vatta M;
    Genet Med; 2023 Jun; 25(6):100812. PubMed ID: 37058144
    [No Abstract]   [Full Text] [Related]  

  • 44. Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.
    Botkin JR; Belmont JW; Berg JS; Berkman BE; Bombard Y; Holm IA; Levy HP; Ormond KE; Saal HM; Spinner NB; Wilfond BS; McInerney JD
    Am J Hum Genet; 2015 Jul; 97(1):6-21. PubMed ID: 26140447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results.
    Bombard Y; Brothers KB; Fitzgerald-Butt S; Garrison NA; Jamal L; James CA; Jarvik GP; McCormick JB; Nelson TN; Ormond KE; Rehm HL; Richer J; Souzeau E; Vassy JL; Wagner JK; Levy HP
    Am J Hum Genet; 2019 Apr; 104(4):578-595. PubMed ID: 30951675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Points to consider in the practice of postmortem genetic testing: A statement of the American College of Medical Genetics and Genomics (ACMG).
    Deignan JL; De Castro M; Horner VL; Johnston T; Macaya D; Maleszewski JJ; Reddi HV; Tayeh MK;
    Genet Med; 2023 May; 25(5):100017. PubMed ID: 36799919
    [No Abstract]   [Full Text] [Related]  

  • 47. One-stop shop for disease genes.
    Baker M
    Nature; 2012 Nov; 491(7423):171. PubMed ID: 23135443
    [No Abstract]   [Full Text] [Related]  

  • 48. The interface of genomic information with the electronic health record: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
    Grebe TA; Khushf G; Chen M; Bailey D; Brenman LM; Williams MS; Seaver LH;
    Genet Med; 2020 Sep; 22(9):1431-1436. PubMed ID: 32475985
    [No Abstract]   [Full Text] [Related]  

  • 49. American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities.
    Kearney HM; South ST; Wolff DJ; Lamb A; Hamosh A; Rao KW;
    Genet Med; 2011 Jul; 13(7):676-9. PubMed ID: 21681105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
    Chao EC; Astbury C; Deignan JL; Pronold M; Reddi HV; Weitzel JN;
    Genet Med; 2021 Jul; 23(7):1179-1184. PubMed ID: 33864022
    [No Abstract]   [Full Text] [Related]  

  • 51. Points to consider to avoid unfair discrimination and the misuse of genetic information: A statement of the American College of Medical Genetics and Genomics (ACMG).
    Seaver LH; Khushf G; King NMP; Matalon DR; Sanghavi K; Vatta M; Wees K;
    Genet Med; 2022 Mar; 24(3):512-520. PubMed ID: 35253645
    [No Abstract]   [Full Text] [Related]  

  • 52. Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
    Deignan JL; Chao E; Gannon JL; Greely HT; Hagman KDF; Mao R; Topper S;
    Genet Med; 2020 Aug; 22(8):1285-1287. PubMed ID: 32404921
    [No Abstract]   [Full Text] [Related]  

  • 53. Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG).
    Del Gaudio D; Shinawi M; Astbury C; Tayeh MK; Deak KL; Raca G;
    Genet Med; 2020 Jul; 22(7):1133-1141. PubMed ID: 32296163
    [No Abstract]   [Full Text] [Related]  

  • 54. DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG).
    Murray MF; Giovanni MA; Doyle DL; Harrison SM; Lyon E; Manickam K; Monaghan KG; Rasmussen SA; Scheuner MT; Palomaki GE; Watson MS;
    Genet Med; 2021 Jun; 23(6):989-995. PubMed ID: 33727704
    [No Abstract]   [Full Text] [Related]  

  • 55. [Medical genetics and the genome].
    Gerdes AM; Vogel I
    Ugeskr Laeger; 2014 Nov; 176(46):. PubMed ID: 25394930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Considerations for policymakers for improving health care through telegenetics: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
    Williams HE; Aiyar L; Dinulos MB; Flannery D; McClure ML; Lloyd-Puryear MA; Sanghavi K; Trotter TL; Viskochil D;
    Genet Med; 2022 Nov; 24(11):2211-2219. PubMed ID: 36040445
    [No Abstract]   [Full Text] [Related]  

  • 57. The clinical application of polygenic risk scores: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
    Abu-El-Haija A; Reddi HV; Wand H; Rose NC; Mori M; Qian E; Murray MF;
    Genet Med; 2023 May; 25(5):100803. PubMed ID: 36920474
    [No Abstract]   [Full Text] [Related]  

  • 58. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.
    Bowdin SC; Hayeems RZ; Monfared N; Cohn RD; Meyn MS
    Clin Genet; 2016 Jan; 89(1):10-9. PubMed ID: 25813238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CAP/ACMG proficiency testing for biochemical genetics laboratories: a summary of performance.
    Oglesbee D; Cowan TM; Pasquali M; Wood TC; Weck KE; Long T; Palomaki GE
    Genet Med; 2018 Jan; 20(1):83-90. PubMed ID: 28661487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
    Li MM; Chao E; Esplin ED; Miller DT; Nathanson KL; Plon SE; Scheuner MT; Stewart DR;
    Genet Med; 2020 Jul; 22(7):1142-1148. PubMed ID: 32321997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.